Tumor diagnosis with new 111In-radioligands based on truncated human gastrin releasing peptide sequences: Synthesis and preclinical comparison

Journal of Medicinal Chemistry

Volumn 56, Issue 21, 2013, Pages 8579-8587

  Marsouvanidis, Panteleimon J ^a,b   Maina, Theodosia ^a   Sallegger, Werner ^c   Krenning, Eric P ^b   De Jong, Marion ^b   Nock, Berthold A ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c piCHEM Research and Development   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN RELEASING PEPTIDE; INDIUM 111; RADIOLIGAND; TETRAXETAN GASTRIN RELEASING PEPTIDE I 111; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SYNTHESIS;

ANIMALS; CELL LINE, TUMOR; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; INDIUM RADIOISOTOPES; MICE; MICE, SCID; MOLECULAR STRUCTURE; NEOPLASMS, EXPERIMENTAL; RECEPTORS, BOMBESIN; TISSUE DISTRIBUTION;

EID: 84887944582     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4010237     Document Type: Article

References (40)

1. Reubi, J. C. Peptide receptors as molecular targets for cancer diagnosis and therapy Endocr. Rev. 2003, 24 (4) 389-427
2. Markwalder, R.; Reubi, J. C. Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation Cancer Res. 1999, 59 (5) 1152-1159
3. Gugger, M.; Reubi, J. C. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast Am. J. Pathol. 1999, 155 (6) 2067-2076
4. Guinee, D. G., Jr.; Fishback, N. F.; Koss, M. N.; Abbondanzo, S. L.; Travis, W. D. The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies Am. J. Clin. Pathol. 1994, 102 (4) 406-414
5. Maina, T.; Nock, B.; Mather, S. Targeting prostate cancer with radiolabelled bombesins Cancer Imaging 2006, 6, 153-157
6. Sancho, V.; Di Florio, A.; Moody, T. W.; Jensen, R. T. Bombesin receptor-mediated imaging and cytotoxicity: Review and current status Curr. Drug Delivery 2011, 8 (1) 79-134
7. Breeman, W. A.; Hofland, L. J.; de Jong, M.; Bernard, B. F.; Srinivasan, A.; Kwekkeboom, D. J.; Visser, T. J.; Krenning, E. P. Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy Int. J. Cancer 1999, 81 (4) 658-665
8. 111In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy J. Nucl. Med. 2002, 43 (12) 1650-1656
9. 99mTc: A preclinical study J. Med. Chem. 2005, 48 (1) 100-110
10. Ananias, H. J.; de Jong, I. J.; Dierckx, R. A.; van de Wiele, C.; Helfrich, W.; Elsinga, P. H. Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals Curr. Pharm. Des. 2008, 14 (28) 3033-3047
11. Zhang, H.; Chen, J.; Waldherr, C.; Hinni, K.; Waser, B.; Reubi, J. C.; Maecke, H. R. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors Cancer Res. 2004, 64 (18) 6707-6715
12. Zhang, H.; Abiraj, K.; Thorek, D. L.; Waser, B.; Smith-Jones, P. M.; Honer, M.; Reubi, J. C.; Maecke, H. R. Evolution of bombesin conjugates for targeted PET imaging of tumors PLoS One 2012, 7 (9) e44046
13. Nanda, P. K.; Pandey, U.; Bottenus, B. N.; Rold, T. L.; Sieckman, G. L.; Szczodroski, A. F.; Hoffman, T. J.; Smith, C. J. Bombesin analogues for gastrin-releasing peptide receptor imaging Nucl. Med. Biol. 2012, 39 (4) 461-471
14. 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer J. Nucl. Med. 2006, 47 (7) 1144-1152
15. 177Lu-DOTA-PESIN) Cancer Res. 2011, 71 (3) 1009-1018
16. Anastasi, A.; Erspamer, V.; Bucci, M. Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes Experientia 1971, 27 (2) 166-167
17. Jensen, R. T.; Battey, J. F.; Spindel, E. R.; Benya, R. V. International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: Nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states Pharmacol. Rev. 2008, 60 (1) 1-42
18. Gonzalez, N.; Moody, T. W.; Igarashi, H.; Ito, T.; Jensen, R. T. Bombesin-related peptides and their receptors: Recent advances in their role in physiology and disease states Curr. Opin. Endocrinol. Diabetes Obes. 2008, 15 (1) 58-64
19. Uehara, H.; Gonzalez, N.; Sancho, V.; Mantey, S. A.; Nuche-Berenguer, B.; Pradhan, T.; Coy, D. H.; Jensen, R. T. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs Peptides 2011, 32 (8) 1685-1699
20. 14]bombesin(6-14) Clin. Cancer Res. 2002, 8 (4) 1139-1146
21. Hohla, F.; Schally, A. V. Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer Cell Cycle 2010, 9 (9) 1738-1741
22. Weber, S.; Zuckerman, J. E.; Bostwick, D. G.; Bensch, K. G.; Sikic, B. I.; Raffin, T. A. Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro J. Clin. Invest. 1985, 75 (1) 306-309
23. Matusiak, D.; Glover, S.; Nathaniel, R.; Matkowskyj, K.; Yang, J.; Benya, R. V. Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288 (4) G718-728
24. 99mTc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): Synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models J. Med. Chem. 2012, 55 (19) 8364-8374
25. 99mTc-Radiotracers based on human GRP(18-27): Synthesis and comparative evaluation J. Nucl. Med. 2013, 54 (10) 1797-1803
26. Cutler, C. S.; Hennkens, H. M.; Sisay, N.; Huclier-Markai, S.; Jurisson, S. S. Radiometals for combined imaging and therapy Chem. Rev. 2013, 113 (2) 858-883
27. Anderson, C. J.; Welch, M. J. Radiometal-labeled agents (non-technetium) for diagnostic imaging Chem. Rev. 1999, 99 (9) 2219-2234
28. 99mTc-radioligands: An effective route for receptor-targeted diagnostic imaging of human tumors Curr. Top. Med. Chem. 2012, 12 (23) 2655-2667
29. 177Lu at high specific activities Eur. J. Nucl. Med. Mol. Imaging 2003, 30 (6) 917-920
30. 3]octreotate prior to administration reduces rat skeleton uptake of radioactivity Eur. J. Nucl. Med. Mol. Imaging 2003, 30 (2) 312-315
31. 177Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC Curr. Top. Med. Chem. 2012, 12 (23) 2677-2685
32. Rolleman, E. J.; Melis, M.; Valkema, R.; Boerman, O. C.; Krenning, E. P.; de Jong, M. Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues Eur. J. Nucl. Med. Mol. Imaging 2010, 37 (5) 1018-1031
33. Gotthardt, M.; van Eerd-Vismale, J.; Oyen, W. J.; de Jong, M.; Zhang, H.; Rolleman, E.; Maecke, H. R.; Behe, M.; Boerman, O. Indication for different mechanisms of kidney uptake of radiolabeled peptides J. Nucl. Med. 2007, 48 (4) 596-601
34. 111In-DTPA-conjugated peptides Nucl. Med. Biol. 2001, 28 (7) 761-768
35. Vegt, E.; de Jong, M.; Wetzels, J. F.; Masereeuw, R.; Melis, M.; Oyen, W. J.; Gotthardt, M.; Boerman, O. C. Renal toxicity of radiolabeled peptides and antibody fragments: Mechanisms, impact on radionuclide therapy, and strategies for prevention J. Nucl. Med. 2010, 51 (7) 1049-1058
36. 111In-labelled gastrin/CCK2 receptor-targeting peptides Eur. J. Nucl. Med. Mol. Imaging 2011, 38 (8) 1410-1416
37. Linder, K. E.; Metcalfe, E.; Arunachalam, T.; Chen, J.; Eaton, S. M.; Feng, W.; Fan, H.; Raju, N.; Cagnolini, A.; Lantry, L. E.; Nunn, A. D.; Swenson, R. E. In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites Bioconjugate Chem. 2009, 20 (6) 1171-1178
38. de Jong, M.; Breeman, W. A.; Kwekkeboom, D. J.; Valkema, R.; Krenning, E. P. Tumor imaging and therapy using radiolabeled somatostatin analogues Acc. Chem. Res. 2009, 42 (7) 873-880
39. 4) bombesin by tumor cells Prostate 1994, 25 (1) 29-38
40. 111In-DOTA] Somatostatin-14 analogs as potential pansomatostatin-like radiotracers-First results of a preclinical study EJNMMI Res. 2012, 2 (1) 25